Sequella's Unattributed - VI Round

Sequella raised a round of funding on October 01, 2013.

Sequella is a clinical stage antiinfectives company focused on discovering, developing, and commercializing improved treatments for serious infectious diseases. The company leverages its global influe…

Articles about Sequella's Unattributed - VI Round: